ESH Video

2nd How to Diagnose and Treat CML / MPN

2nd How to Diagnose and Treat CML / MPN
March 05 - March 07, 2021 - Warsaw, Poland
Chairs : Claire Harrison, Andreas Hochhaus, Ruben Mesa

Information

2nd How to Diagnose and Treat CML / MPN
March 5-7, 2021
Warsaw, Poland
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa


Programme Summary:

This second meeting organized by ESH to focus in depth upon the clinical management of patients with chronic myeloid leukemia and the myeloproliferative neoplasms, builds on the experiences and scientific progress since the highly successful Inaugural “How to Treat CML and MPNs” held in Dublin in March 2019. This “ 2nd How to Diagnose and Treat CML and MPNs” uses a case-based format to scrutinise with experts in the field relevant issues in diagnosis, prognostication, therapy selection, efficacy assessment, and management of toxicities for these patients. The format for this meeting will be highly interactive with a mixture of case-based didactic lectures, roundtable discussions regarding challenging clinical scenarios, and debates on controversial areas of management. This first ESH meeting for MPNs occurring since the onset of the COVID19 Pandemic will cover the specific patient implications for CML and MPN patients. The faculty for this event represent the clinical and scientific leaders of the MPN community from around the world and we anticipate great opportunities for interactions and discussions. Clinical haematologists, hematology nurses, clinician scientists, hematology investigators, and those in training will find great value in attending and participating in this event.

 

This meeting will be valuable to you if you are looking for:

This unique meeting will be an intimate workshop with a case-based approach where active practicing haematologists and associated specialties will be able to learn from and interact with the global thought leaders in CML and MPNs. Participants will gain at the meeting better insights into managing both common and uncommon clinical scenarios for these patients and return home to apply this knowledge for their patients. Many of the lessons learned relevant to MPN and CML management from the COVID19 Pandemic will be discussed (risks, medicine dosing, thrombosis issues, use of electronic virtual visits in care).

 

Learning Objectives:

  • To understand the current diagnostic criteria for MPNs and CML, and their application particularly in challenging scenarios
  • To better understand the role of molecular mutation testing in diagnosis, prognosis, therapy selection and disease monitoring for CML and MPN patients
  • To be able to appreciate the clinical management of challenging scenarios in MPNS (i.e. early MF, accelerated phase MPN, CML-MPN overlap, pregnancy and parenting, and CML blast crisis)
  • To better understand and apply current guideline based management of CML and MPNs including stem cell transplant,
  • To be able to review the role and utilization of current approved therapies in CML and MPNs (interferons, JAK inhibitors, TKIs), as well as the potential role of agents in development.
  • To discuss evolving issues of COVID19 (and other infectious risks) and management of MPNs and CML

 

Topics:

  • Optimizing cytoreduction
  • Management of CML with TKI 
  • MPN risk stratification including vascular events
  • Evolving therapies in Myelofibrosis 
  • Management of advanced disease (MPN and CML)  
  • Treatment free remission in CML

 

The programme will include:

  • Plenary Sessions
  • Interactive Cases Presentations
  • Roundtables
  • Panel Discussions
  • Debates
  • Poster Presentations
  • Voting Boxes

 

 

Programme

Please click HERE to see the scientific programme.

Abstract submission

DEADLINE FOR ABSTRACTS AND CLINICAL CASES: JANUARY 5th, 2021

Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 400
– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

Symposia

Accommodation

Venue

Corporate partners

With the support off*:

Novartis

Major Conference Partner

*****

 Constellation

Level 2 Conference Partner

*****

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

 

Scholarships

Workshop

Educational Grants

Registration

The registration fee for the “2nd How to Diagnose and Treat CML/MPN” is:
– 600€  for fully trained
– 300€ for in-training
– 300€ for Allied Health Professional

A proof will be requested to confirm your status.

This fee includes:
Your seat in the Conference Room
The conference materials,
Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

 

How to proceed :
Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

A) For Individual Registration:
1. Click on REGISTER HERE at the bottom of the page
2. Click on INDIVIDUAL REGISTRATION
3. Create an account and complete the registration form. It is very important to use the email of the participant in the form.
4. Proceed with the payment.

B) For Group Registration (More than one person):
1. Click on REGISTER HERE at the bottom of the page
2. Click on GROUP REGISTRATION
3. Create an account and fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)
4. Proceed with payment.


Cancellation policy of registration fee
 :
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA, MASTERCARD/EUROCARD, AMEX and CB.

 

Register HereBSH Member Register Here